Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.
If you are interested in participating, and want to know if you may qualify, please visit www.helpmylowt.com or call 800-895-6554 ext 3403.
Current recruiting locations:
Androxal® - Pharmacokinetic and Safety Profile of Androxal in Male Subjects with Impaired Renal Function (ZA-104) (Currently Recruiting)
Purpose: To determine and compare the pharmacokinetics (PK) and safety profile of a single dose of 25 mg Androxal in overweight male subjects with various stages of renal impairment and in volunteers with normal renal function.
Androxal® - Pharmacokinetics and Safety of Androxal in Male Subjects with Impaired Hepatic Function (ZA-105) (Currently Recruiting)
Purpose: To determine and compare the pharmacokinetics (PK) and safety profile of a single dose of 25 mg Androxal in overweight male subjects with hepatic impairment and in volunteers with normal hepatic function.
Androxal® - An Open Label, Escalating Dose, Safety Study for Treatment of Men with Secondary Hypogonadism (ZA-300) (Recruitment Closed)
Purpose: To determine the safety profile of Androxal in men with secondary hypogonadism.
Androxal® - Normalization of Morning Testosterone Levels in Overweight Men Less Than 60 Years of Age with Secondary Hypogonadism (ZA-302) (Recruitment Closed)
Purpose: Purpose: To determine the effects of Androxal on morning testosterone and reproductive status in younger overweight men with acquired hypogonadotropic hypogonadism (confirmed morning T<300 ng/dL) and normal sperm concentration, compared to changes with placebo.
Androxal® - An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism (ZA-301ext) (Enrollment by invitation only)
Purpose: To evaluate the safety on continued treatment with Androxal in subjects who completed either ZA-301 or ZA-302.
Androxal® - Assess the Effects on Bone Mineral Density (ZA-303) (Recruitment Closed)
Purpose: To determine the effects of 12 months of treatment with Androxal on Bone Mineral Density in men with secondary Hypogonadism.
If you are interested in participating, and want to know if you may qualify, please call 800-895-6554 ext 3401.
Current recruiting locations:
Little Rock, AR
Miami Gardens, FL
Pleasant Grove, UT
Salt Lake City, UT
Proellex®- Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Currently recruiting)
Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.
Proellex® - Extension Study for Premenopausal Women with Uterine Fibroids Who Have Completed ZPV-200 (ZPV-200ext) (Invitation Only - Recruitment Closed)
Purpose: To further determine the safety and efficacy of Proellex in premenopausal women with uterine fibroids who have previously completed study ZPV-200.